Inside a top healthcare dealmaker's next chapter

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

• Inside a legendary healthcare dealmaker's next chapter;
• Investors are pouring millions into online abortion care startups;
• How 3 concerning variants that have emerged since Delta compare.

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

---

Shannon Stapleton/Reuters; Patient Square Capital; Bobby Yip/Reuters; Samantha Lee/Insider

Jim Momtazee walked away from private equity giant KKR to strike out on his own. Now the legendary healthcare dealmaker is poised to break records with his new firm.

• Jim Momtazee was KKR's top healthcare dealmaker before leaving the private equity giant in 2019.
• Momtazee now has his own firm and is aiming to raise a record-setting $3 billion first fund.
• Healthcare is a red-hot sector. But, the pandemic has made it even harder for new investment firms to raise funds.

Find out more>>

---

The abortion pill is legal in all fifty states.

Cavan Images/ Getty Images

Startup founders and VCs are stepping up as states like Texas restrict abortion access

• As Texas restricts abortion care, companies are raising millions to offer the service online.
• Hey Jane, Choix, and Just the Pill prescribe abortion medication online.
• Venture backers say these sites could be an entryway into the lucrative women's healthcare market.

Get the full story>>

---

A medical worker performs a PCR test for COVID-19 on August 31, 2020, at a testing booth in Montreuil, France.

Alain Jocard/AFP/Getty Images

3 concerning variants have caught scientists' attention since Delta emerged - here's how they compare

• Three coronavirus variants - Lambda, Mu, and C.1.2 - have raised red flags among scientists lately.
• The variants show signs of being highly transmissible, able to circumvent vaccine protection, or both.
• But so far, none is more concerning than Delta, the world's dominant strain.

See how they compare>>

---

More stories we're reading:

• Pfizer picked a COVID-19 vaccine dose far lower than Moderna's to minimize side effects, its top scientist says (Insider)
• Verily's at a critical moment where it needs to turn its biggest ideas into a profitable business (Stat News)
• Theranos founder Elizabeth Holmes' fraud trial is now underway. Here are some of the big players listed as potential witnesses in the case. (Insider)
• Dollar General CEO: About 65% of the discount retailer's stores are in "health deserts" (CNBC)

---

- Lydia

Read the original article on Business Insider

from Business Insider https://ift.tt/2X1Ktre